Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 21.09.2026 1 Acta Ophthalmol 2 Am J Clin Nutr 3 Ann Intern Med 3 Diabet Med 5 Diabetes 7 Diabetes Care 16 Diabetes Obes Metab 9 Diabetologia 2 Invest Ophthalmol Vis Sci 1 J Am Soc Nephrol 3 J Clin Endocrinol Metab 2 J Clin Invest 3 J Diabetes Complications 2 JAMA 3 Kidney Int 1 Metabolism 1 Ophthalmol Glaucoma 1 Ophthalmol Retina 1 Ophthalmology 9 PLoS One 1 Stroke

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. VUJOSEVIC S, Ginelli S, Cernuschi A, Limoli C, et al
   Longitudinal progression of retinal nonperfusion in clinically stable diabetic retinopathy.
   Acta Ophthalmol. 2026 Sep 15. doi: 10.1111/aos.70223.
   PubMed         Abstract available
   
   

   
   Am J Clin Nutr

2. DOMINGUEZ-LOPEZ I, Eichelmann F, Parilli-Moser I, Hurtado-Barroso S, et al
   Peanuts-derived plasma lipids and lower risk of type-2 diabetes: Association mediated by body mass index. An intervention and case-cohort study.
   Am J Clin Nutr. 2026 Sep 17:101527. doi: 10.1016/j.ajcnut.2026.101527.
   PubMed         Abstract available
   
   
3. HERNANDEZ TL, Farabi SS, Fosdick BK, Hirsch N, et al
   A Higher-Complex Carbohydrate vs Conventional Low-Carbohydrate Diet in Gestational Diabetes Mellitus results in Lower Postprandial Free Fatty Acids: A Randomized Controlled Trial.
   Am J Clin Nutr. 2026 Sep 16:101525. doi: 10.1016/j.ajcnut.2026.101525.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. DAVIDSON MB
   In adults with early uncontrolled T2D, tirzepatide vs. intensified conventional care reduced HbA(1c) levels and weight at 2 y.
   Ann Intern Med. 2026;179:JC98.
   PubMed         Abstract available
   
   
5. REYNOLDS KR, O'Malley KM, Roy JA, Dave CV, et al
   Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy : A Target Trial Emulation.
   Ann Intern Med. 2026;179:1244-1253.
   PubMed         Abstract available
   
   
6. UEDA P, Svanstrom H, Soderling J, Pazzagli L, et al
   Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.
   Ann Intern Med. 2026;179:1232-1243.
   PubMed         Abstract available
   
   

   
   Diabet Med

7. MUNOZ-CRUZ JC, Lopez-Martinez C, Del-Pino-Casado R
   Parental monitoring and therapeutic adherence in adolescents and young adults with type 1 diabetes mellitus: Systematic review with meta-analysis.
   Diabet Med. 2026 Sep 15:e70477. doi: 10.1111/dme.70477.
   PubMed         Abstract available
   
   
8. LITTERBACH E, Spence AC, Middleton G, Speight J, et al
   Family meals for future health: A life-course approach to type 2 diabetes risk reduction after gestational diabetes.
   Diabet Med. 2026 Sep 16:e70476. doi: 10.1111/dme.70476.
   PubMed         Abstract available
   
   
9. HO F, Kyi M, Fourlanos S, Barmanray RD, et al
   Opportunities to improve perioperative glycaemia in hospital inpatients with diabetes and hyperglycaemia.
   Diabet Med. 2026 Sep 18:e70482. doi: 10.1111/dme.70482.
   PubMed        
   
   

   
   Diabetes

10. XU W, Chen T, Zhang W, Sakal C, et al
    Associations of Ultraprocessed Food Intake, Wearable-Measured Lifestyle Factors, and Genetic Susceptibility With Incident Type 2 Diabetes.
    Diabetes. 2026 Sep 17:db260395. doi: 10.2337/db26-0395.
    PubMed         Abstract available
    
    
11. MA D, Liang X, Jing H, Liu X, et al
    Lysine Lactylation Modifies Cryab-Hspa1b Interactions and Prevents MAPK Signaling to Slow Diabetic Cardiomyopathy Progression.
    Diabetes. 2026 Sep 17:db260432. doi: 10.2337/db26-0432.
    PubMed         Abstract available
    
    
12. GONZALEZ-GONZALEZ L, Dreffs A, Lin CM, Liu X, et al
    Norrin Treatment Prevents Vascular Permeability and Neural Cell Loss While Preserving Vision in Diabetic Rats.
    Diabetes. 2026 Sep 15:db260340. doi: 10.2337/db26-0340.
    PubMed         Abstract available
    
    
13. YANG G, Tian Y, Sun R, Dong C, et al
    Inulin- and Butyrate-Mediated HIF-1alpha Butyrylation Prevent Diabetic Ferroptosis and Cardiomyopathy by Maintaining Iron Homeostasis.
    Diabetes. 2026 Sep 15:db260063. doi: 10.2337/db26-0063.
    PubMed         Abstract available
    
    
14. KONDO A, Ikeda K, Kaneko S, Harashima S, et al
    Insulin Dosing Is Associated With Cardiac Sympathetic Predominance Independent of Glycemic Profiles in Type 1 Diabetes Under Free-Living Conditions.
    Diabetes. 2026 Sep 14:db260456. doi: 10.2337/db26-0456.
    PubMed         Abstract available
    
    

    
    Diabetes Care

15. DE BEAUFORT C, James S, Weissberg-Benchell J, Gomber A, et al
    The Transition of Youth With Diabetes From Pediatric to Adult Diabetes Care Services: A Consensus Report of the Joint Working Group of the International Society for Pediatric and Adolescent Diabetes (ISPAD), the European Association for the Study of D
    Diabetes Care. 2026 Sep 14:dci260097. doi: 10.2337/dci26-0097.
    PubMed         Abstract available
    
    
16. HENNESSY C, Abram S, Brown R, Loizou C, et al
    All-Cause Mortality, Morbidity, and Reamputation Rates Following Below-Knee Amputation in 25,176 People With Diabetes: A 25-Year England Population Study.
    Diabetes Care. 2026 Sep 14:dc261100. doi: 10.2337/dc26-1100.
    PubMed         Abstract available
    
    
17. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    The Management of Type 1 Diabetes in Adults. The Updated 2026 Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetes Care. 2026 Sep 15:dci260122. doi: 10.2337/dci26-0122.
    PubMed         Abstract available
    
    
18. ROBINSON-ECTOR KS, Day H, Begle C, Miller KEM, et al
    Access to Primary Care and Endocrinology Care Among Medicare Beneficiaries With Type 1 and Type 2 Diabetes, 2017-2021.
    Diabetes Care. 2026 Sep 15:dc262070. doi: 10.2337/dc26-2070.
    PubMed        
    
    
19. YOO JH, Kim S, Park Y, Park S, et al
    Three-Year Glycemic Trajectories in Subgroups With Type 1 Diabetes at Risk for Suboptimal Glycemic Control: A Multicenter Continuous Glucose Monitoring Study.
    Diabetes Care. 2026 Sep 16:dc261039. doi: 10.2337/dc26-1039.
    PubMed         Abstract available
    
    
20. MOHAN V, Sathweek RS, Anjana RM, Unnikrishnan R, et al
    Making Modern Diabetes Medications Affordable and Accessible: Lessons From India for Other Countries.
    Diabetes Care. 2026 Sep 16:dci260054. doi: 10.2337/dci26-0054.
    PubMed         Abstract available
    
    
21. BAKHSHI B, Lin H, Sultana N, Healey E, et al
    Beyond Traditional Glycemic Measures: CGM Glycemic Profiles Reveal Associations With Cardiometabolic Risk in Individuals Without Diabetes.
    Diabetes Care. 2026 Sep 17:dc261197. doi: 10.2337/dc26-1197.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

22. LE FOLL C, Lutz TA
    Amylin: A Multi-Functional Pancreatic Hormone-A Review.
    Diabetes Obes Metab. 2026;28 Suppl 5.
    PubMed         Abstract available
    
    
23. KOO DJ, Park JY, Han K, Lee WY, et al
    Layered Effects of LDL-C Burden and Variability on Cardiovascular Events and Mortality in Type 2 Diabetes: A Nationwide Cohort Study.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71356.
    PubMed         Abstract available
    
    
24. KIM T, Vu A, Ali Z, Kim E, et al
    Chronic Kidney Disease Severity and Progression to Proliferative Diabetic Retinopathy.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71368.
    PubMed         Abstract available
    
    
25. LAMPRECHT-CARSON D, Wang H, Chang SH, McElfish PA, et al
    Cost-Effectiveness of a Culturally Adapted Diabetes Self-Management Education Program for Marshallese Adults With Type 2 Diabetes-a State-Transition Markov Analysis.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71351.
    PubMed         Abstract available
    
    
26. AJIE M, Ali N, Hendriksz MS, Divilly P, et al
    Sensor-Detected Hypoglycaemia Is Associated With Inflammatory Protein and Immune Cell Alterations in People With Diabetes: Findings From the Hypo-METRICS Study.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71321.
    PubMed         Abstract available
    
    
27. ZHOU Y, Ni Y, Deng H, Lin Q, et al
    Early Use of Automated Insulin Delivery With Telehealth Support in People Recently Diagnosed With Type 1 Diabetes: One-Year Outcomes From a Prospective Observational Study.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71347.
    PubMed         Abstract available
    
    
28. HOHENDORFF J, Klupa T, Wrobel M, Grzelka-Wozniak A, et al
    Metabolic and Psychological Effects of Mylife CamAPS FX Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes, Markedly Elevated HbA1c, and Psychological Vulnerability: The Hi-Loop Randomised Clinical Trial.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71339.
    PubMed         Abstract available
    
    
29. JI L, Yang G, Huang Y, Ding H, et al
    Effectiveness, Safety and Pharmacokinetics of BGM0504, a Dual GLP-1/GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71193.
    PubMed         Abstract available
    
    
30. ZHOU Z, Fu L, Chen D, Yu P, et al
    Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71305.
    PubMed         Abstract available
    
    
31. SHINDE S, Kahles F, Vasileva-Metodiev S, Griffin R, et al
    Predicting the Long-Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN-1 Trial.
    Diabetes Obes Metab. 2026 Sep 17. doi: 10.1111/dom.71322.
    PubMed         Abstract available
    
    
32. TATTERSALL Z, Ng SM
    Managing Type 1 Diabetes in Neurodiverse Children and Young People: A Qualitative Exploration of Complexity and Care Challenges.
    Diabetes Obes Metab. 2026 Sep 15. doi: 10.1111/dom.71363.
    PubMed         Abstract available
    
    
33. YANG H, Ren T, Zhou J, Liu H, et al
    GLP-1 Receptor Agonist-Based Prandial Insulin De-Intensification in Outpatients With Type 2 Diabetes Receiving Basal-Bolus Insulin Therapy or Multiple Daily Injections: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Diabetes Obes Metab. 2026 Sep 14. doi: 10.1111/dom.71359.
    PubMed         Abstract available
    
    
34. TRAN TH, Kim HS, McCoy RG, Zafari Z, et al
    Real-World Cost and Utilisation Burden of Diagnosed Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes in the United States: A Retrospective Cohort Study.
    Diabetes Obes Metab. 2026 Sep 14. doi: 10.1111/dom.71355.
    PubMed         Abstract available
    
    
35. ZHANG D, Lu Y, Jian X, Wang H, et al
    Association of GLP-1 Receptor Agonists With Gastrointestinal and Liver Outcomes in Adults With Type 2 Diabetes: A Target Trial Emulation Study.
    Diabetes Obes Metab. 2026 Sep 14. doi: 10.1111/dom.71352.
    PubMed        
    
    
36. XIE Y, Li J, Ye T
    Distinguishing Biology From Clinical Surveillance in Postpartum Biomarker Trajectories After Gestational Diabetes.
    Diabetes Obes Metab. 2026 Sep 13. doi: 10.1111/dom.71346.
    PubMed        
    
    
37. PERRY F, Leon SJ, Polecina K, Getachew R, et al
    Effects of Renin-Angiotensin Inhibitors, Sodium-Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon-Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta-
    Diabetes Obes Metab. 2026 Sep 13. doi: 10.1111/dom.71337.
    PubMed         Abstract available
    
    

    
    Diabetologia

38. KAHN SE, Anderson CAM, Buse JB, Selvin E, et al
    What has happened to the American Diabetes Association? The Diabetes Care editors turn to Diabetologia to publish without restrictions.
    Diabetologia. 2026 Sep 16. doi: 10.1007/s00125-026-06860.
    PubMed        
    
    
39. LIANG C, Dobson AJ, Doust J, Ribeiro LW, et al
    Menopause hormone therapy and type 2 diabetes risk and prognosis: systematic review and meta-analyses.
    Diabetologia. 2026 Sep 18. doi: 10.1007/s00125-026-06856.
    PubMed         Abstract available
    
    
40. KEECH AC, O'Connell RL, Januszewski AS, Li L, et al
    Indices of obesity, malnutrition and inflammation are strong predictors of mortality in adults with type 2 diabetes: the FIELD study.
    Diabetologia. 2026 Sep 17. doi: 10.1007/s00125-026-06848.
    PubMed         Abstract available
    
    
41. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2026 Sep 16. doi: 10.1007/s00125-026-06833.
    PubMed         Abstract available
    
    
42. 
    What has happened to the American Diabetes Association? The Diabetes Care editors turn to Diabetologia to publish without restrictions. Reply to Kahn SE, Anderson CAM, Buse JB, Selvin E [letter].
    Diabetologia. 2026 Sep 16. doi: 10.1007/s00125-026-06868.
    PubMed        
    
    
43. SARGENT JL, Mulder H
    Standing together for diabetes.
    Diabetologia. 2026 Sep 16. doi: 10.1007/s00125-026-06861.
    PubMed        
    
    
44. SPEIGHT J, Hermanns N, Jensen W, Kanc K, et al
    2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes or type 2 diabetes.
    Diabetologia. 2026 Sep 15. doi: 10.1007/s00125-026-06840.
    PubMed         Abstract available
    
    
45. JAMES E, Henson J, Davies MJ, Khunti K, et al
    Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials.
    Diabetologia. 2026 Sep 14. doi: 10.1007/s00125-026-06873.
    PubMed         Abstract available
    
    
46. DE BEAUFORT C, James S, Weissberg-Benchell J, Gomber A, et al
    The transition of youth with diabetes from paediatric to adult diabetes care services: a consensus report of the joint working group of the International Society for Pediatric and Adolescent Diabetes (ISPAD), the European Association for the Study of
    Diabetologia. 2026 Sep 14. doi: 10.1007/s00125-026-06803.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

47. LIU Q, Liu Y, Yang X, Liu T, et al
    Integrated Multi-Tissue Omics Identifies Acylcarnitine Accumulation as Shared Metabolic Marker of Diabetic Microangiopathy With Cross-Organ Validation.
    Invest Ophthalmol Vis Sci. 2026;67:31.
    PubMed         Abstract available
    
    
48. SHAH J, Niktinat H, Kakihara S, Fawzi AA, et al
    Outer Retinal Volume on Macular OCT Predicts Two-Year Diabetic Retinopathy Progression.
    Invest Ophthalmol Vis Sci. 2026;67:35.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

49. FU J, Niu Y, Chang D, Sun Z, et al
    Spatially Distinct TREM2+ Macrophages Are Associated with Compartment-Specific Protection in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2026 Sep 14. doi: 10.1681/ASN.0000001248.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

50. SABBE A, Bochanen N, Van den Broucke A, Mihaljcic K, et al
    Association between worsening time in range and microvascular complications in type 1 diabetes: real-world 5-year study.
    J Clin Endocrinol Metab. 2026 Sep 16:dgag380. doi: 10.1210.
    PubMed         Abstract available
    
    
51. KNORR S, Knudsen TS, Kirkegaard K, Hviid KVR, et al
    Glucose excursions throughout the reproductive life stages in women with diabetes.
    J Clin Endocrinol Metab. 2026 Sep 15:dgag379. doi: 10.1210.
    PubMed         Abstract available
    
    
52. YANG J, Zhang X, Luo L, Zheng Z, et al
    Pancreatic fat and the risk of future dysglycemia: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2026;111:2994-3003.
    PubMed         Abstract available
    
    

    
    J Clin Invest

53. PETERS LD, Seay HR, Smith JA, Posgai AL, et al
    Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes.
    J Clin Invest. 2026;136:e196445.
    PubMed         Abstract available
    
    
54. SAMASSA F, You S, Mallone R
    Going to the source: pancreatic lymph nodes maintain stem-like CD8+ T cells in human type 1 diabetes.
    J Clin Invest. 2026;136:e209019.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

55. DAVIS TME, Drinkwater JJ, James AG, Holmes E, et al
    Lipidomic profiles and their relationship to incident diabetic retinopathy in type 2 diabetes: The Fremantle Diabetes Study Phase II.
    J Diabetes Complications. 2026;40:109412.
    PubMed         Abstract available
    
    
56. LARSEN RG, Croosu SS, Roikjer J, Hansen RK, et al
    Impact of diabetic peripheral neuropathy on skeletal muscle microvascular function: A blood oxygen level dependent magnetic resonance imaging study.
    J Diabetes Complications. 2026;40:109414.
    PubMed         Abstract available
    
    
57. CUI Z, Zhang Z, Li X, Liu Y, et al
    Significant decrease of serum extracellular vesicle neuropilin-1 in type 2 diabetes mellitus patients with endothelial dysfunction: a cross-sectional study.
    J Diabetes Complications. 2026;40:109411.
    PubMed         Abstract available
    
    

    
    JAMA

58. MITAL S, Haller MJ, Schatz DA
    Screening for Early-Stage Type 1 Diabetes in Children.
    JAMA. 2026 Sep 16. doi: 10.1001/jama.2026.14521.
    PubMed        
    
    
59. BONIFACIO E, Winkler C, Ziegler AG
    Screening for Early-Stage Type 1 Diabetes in Children-Reply.
    JAMA. 2026 Sep 16. doi: 10.1001/jama.2026.14524.
    PubMed        
    
    

    
    Kidney Int

60. LIANG X, Wang P, Chen B, Ge Y, et al
    Corrigendum to "Glycogen synthase kinase 3beta hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease." Kidney Int. 2020;97:175-192.
    Kidney Int. 2026;110:1072-1075.
    PubMed        
    
    
61. CAZA TN, Walker PD
    Authors' response to "Actionable yield of kidney biopsy in diabetic kidney disease".
    Kidney Int. 2026;110:1049.
    PubMed        
    
    
62. LI J, Nie H, Ao G
    Actionable yield of kidney biopsy in diabetic kidney disease.
    Kidney Int. 2026;110:1048.
    PubMed        
    
    

    
    Metabolism

63. YAO J, Tai ES, Sim X, Muller-Riemenschneider F, et al
    Dose-response associations of whole-body and regional body fat with continuous glucose monitoring-derived glycemic level and glycemic variability: A cross-sectional study of Asian adults without diabetes.
    Metabolism. 2026 Sep 16:156782. doi: 10.1016/j.metabol.2026.156782.
    PubMed         Abstract available
    
    

    
    Ophthalmol Glaucoma

64. MARGOLIS R, Vasu P, Dorairaj SK
    Long-Term Risk of Mortality and Systemic Morbidity in Neovascular Glaucoma: A Multicenter Retrospective Cohort Study.
    Ophthalmol Glaucoma. 2026 Feb 5:S2589-4196(26)00017.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

65. LEE DH, VanderBeek BL
    The Significance of Assessing Systemic Factors in Diabetic Macular Edema.
    Ophthalmol Retina. 2026 Sep 17:S2468-6530(26)00418.
    PubMed        
    
    

    
    Ophthalmology

66. KHURANA RN
    Mind the Gap: The Urban-Rural Divide in Diabetic Retinopathy Care in the United States.
    Ophthalmology. 2026 Sep 18:S0161-6420(26)00677.
    PubMed        
    
    

    
    PLoS One

67. AHMADASADI H, Rasouli Emamgholi P, Layali I, Kianfar T, et al
    Exploring the link between asprosin and glucose and lipid dysregulation in offspring of diabetic mothers in a rat model.
    PLoS One. 2026;21:e0354870.
    PubMed         Abstract available
    
    
68. DANG PG, Chen YP, Nguyen TT, Nguyen DH, et al
    Association of type 2 diabetes mellitus with postoperative outcomes following single-level endoscopic lumbar interbody fusion through a posterior approach: A global propensity score-matched cohort study.
    PLoS One. 2026;21:e0358422.
    PubMed         Abstract available
    
    
69. ROY S, Iktidar MA, Mannan Liza M, Bhadra Medha MR, et al
    Factors associated with medication adherence among adult diabetic patients of Bangladesh.
    PLoS One. 2026;21:e0343647.
    PubMed         Abstract available
    
    
70. QIU X, Guan L, Liu H
    Global burdens of diabetes mellitus in adolescents from 1990 to 2023 and future trend predictions: An analysis of the Global Burden of Disease study 2023.
    PLoS One. 2026;21:e0358475.
    PubMed         Abstract available
    
    
71. WISE IA, Berry SD, McKenzie A, Steel JC, et al
    Exploring systemic erythropoietin in diabetic retinopathy: Longitudinal associations and biomarker potential in the LANDMark cohort.
    PLoS One. 2026;21:e0358455.
    PubMed         Abstract available
    
    
72. MUSYOKI VM, Mureithi M, Heikinheimo A, Maleche-Obimbo E, et al
    Temporal patterns of tuberculosis-associated hyperglycaemia and its effect on treatment outcomes in individuals not previously diabetic: A prospective cohort study.
    PLoS One. 2026;21:e0358593.
    PubMed         Abstract available
    
    
73. LI Z, Zhang W, Fang D, Zhao B, et al
    Associations between serum lactate and renal dysfunction in diabetic kidney disease: An exploratory analysis integrating animal experiments, clinical cohorts, and bioinformatic approaches.
    PLoS One. 2026;21:e0358359.
    PubMed         Abstract available
    
    
74. AWAN SF, Irfan K, Butt UM, Letchmunan S, et al
    Explainable diabetes prediction using a stacked ensemble framework.
    PLoS One. 2026;21:e0352313.
    PubMed         Abstract available
    
    
75. YOOYEN K, Bunditpirom S, Fucharoen S, Chaibunruang A, et al
    Prevalence and factors associated with anemia among patients with type 2 diabetes mellitus in northeastern Thailand: A cross-sectional study.
    PLoS One. 2026;21:e0358120.
    PubMed         Abstract available
    
    

    
    Stroke

76. YANG W, Lee JS, Kim BJ, Chang JY, et al
    Sodium-Glucose Cotransporter 2 Inhibitor Use and Functional Outcomes After Endovascular Thrombectomy in Diabetic Stroke.
    Stroke. 2026 Sep 14. doi: 10.1161/STROKEAHA.126.056159.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum